Boston Scientific diskutieren
Boston Scientific
WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /
79,00 €
0,77 %
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Truist Financial Co. from $100.00 to $110.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $108.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $101.00 to $119.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Piper Sandler from $95.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $107.00 to $122.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Morgan Stanley from $100.00 to $120.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $118.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Stifel Nicolaus from $100.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $105.00 to $116.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $119.00 to $122.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $105.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $111.00 to $118.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target lowered by analysts at Truist Financial Co. from $120.00 to $113.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $113.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Robert W. Baird from $115.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Evercore ISI from $110.00 to $112.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Truist Financial Co. from $113.00 to $117.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $116.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Needham & Company LLC from $113.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Neueste Beiträge
Morgan_Stanley in Hasbro Inc. diskutieren